Key statistics
On Tuesday, Oramed Pharmaceuticals Inc (ORMP:TLV) closed at 1,072.00, -10.52% below its 52-week high of 1,198.00, set on Jan 15, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1,042.00 |
|---|---|
| High | 1,072.00 |
| Low | 1,029.00 |
| Bid | 1,044.00 |
| Offer | 935.10 |
| Previous close | 1,051.00 |
| Average volume | 7.29k |
|---|---|
| Shares outstanding | 39.80m |
| Free float | 33.98m |
| P/E (TTM) | 3.39 |
| Market cap | 135.73m USD |
| EPS (TTM) | 1.01 USD |
Data delayed at least 20 minutes, as of Feb 10 2026 15:24 GMT.
More ▼
Press releases
- Oramed and Lifeward Announce Strategic Transaction
- Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
- Oramed Reports Fiscal Third Quarter 2025 Financial Results
- ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
